Target intelligence / Profile preview

Crotaline snake venom toxins

Molecular classification
Enzyme, Peptide toxin, Metalloproteinase, Myotoxin, Neurotoxin, Cytotoxin
01

Overview

Crotaline snake venom toxins are a complex assembly of bioactive proteins and peptides produced by snakes of the subfamily Crotalinae (pitvipers), including rattlesnakes. Major toxin types include snake venom metalloproteinases (SVMPs), phospholipases A2 (PLA2s), serine proteases, and small nonenzymatic toxins such as crotamine (a β-defensin-like myotoxin). These molecules exhibit diverse mechanisms: enzymatic toxins disrupt tissue and blood vessel integrity, leading to hemorrhage and inflammation, while nonenzymatic toxins like crotamine induce muscle contraction and cell death through ion channel modulation. Crotaline venoms cause local and systemic toxicity, including pain, cytotoxicity, bleeding, and, in some cases, cardiovascular collapse. Therapeutically, these toxins represent important targets for antivenom development and are studied for potential applications in biotechnology and drug discovery. Due to the heterogeneous nature of these toxins, the entry "Crotaline snake venom toxins" should be parsed into individual molecular target entries for precise database annotation.

Other names
Pitviper venom toxinsrattlesnake venom toxinscrotalid toxin(s)crotaminemyotoxin-αβ-defensin-like toxin
02

Mechanism of action

Enzyme inhibition (SVMP, PLA2 inhibitors); Neutralization via antibody binding (antivenom); Inhibition of ion channel interaction (for crotamine and β-defensin-like toxins)

03

Biological functions

Cell death (cytotoxicity)Muscle contraction (myotoxicity)Membrane depolarizationApoptosisImmune response modulationDisruption of hemostasis (bleeding, clotting disorders)Signal transduction (via ion channels and proteoglycan interactions)
04

Disease associations

InflammationCardiovascular disease (disruption of coagulation)Infection (potential antimicrobial activity)PainOther (namely tissue necrosis, hemorrhage, and edema following envenomation)
05

Safety considerations

High risk of cytotoxicity, myotoxicityPotential for severe tissue damage, necrosis, hemorrhage, organ damageRisk of immune responses and allergic events to antivenom
06

Interacting drugs

Antivenoms (specific to crotaline snakes; often polyvalent)

2 more in the full profile.

07

Biomarkers

Circulating venom antigen (for snakebite diagnosis/efficacy monitoring)Creatine kinase (muscle injury)Coagulation markers (prothrombin time, fibrinogen levels)

Beyond the preview

Go deeper on Crotaline snake venom toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crotaline snake venom toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call